Vimarsana
Biggest News Aggregation in the World

Prospective Randomized Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prospective Randomized Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prospective Randomized Trial Today - Breaking & Trending Today

New Study Confirms HeartFlow FFRCT Leads to Improved Patient Outcomes - Vimarsana News

New Study Confirms HeartFlow FFRCT Leads to Improved Patient Outcomes

University Hospitals Harrington Heart & Vascular Institute first to adopt technology in U.S. 

Late-Breaking Data Demonstrate AHA/ACC Guideline-Directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing - Vimarsana News

Late-Breaking Data Demonstrate AHA/ACC Guideline-Directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing

Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more accurate non-invasive diagnosis, fewer unnecessary tests, and higher confidence in identifying patients needing treatment

HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions - Vimarsana News

HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions

12 month data from The PRECISE Trial, the first global, prospective, randomized trial comparing diagnosis and evaluation pathways for stable chest pain, will be presented at the AHA 2022 Scientific Sessions.